Zalunfiban acetate

N/A

Report date: 2025/06/10 10:17:15
NME

Base Information

Drug NameZalunfiban acetate
Drug Alias NameZalunfibanRUC-4RUC-4 acetate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsST Elevation Myocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A

Develop Information

Active CompaniesCelecor Therapeutics
Inactive CompaniesN/A
Active IndicationsST Elevation Myocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A